Novel pharmacological TRPC inhibitors block hypoxia-induced vasoconstriction
Authors:
- Kerstin HillKHKerstin Hill
- Liming WangLWLiming Wang
- Wolfgang M. KueblerWKWolfgang M. Kuebler
- Michael SchaeferMSMichael Schaefer
- 1 February 2012
- journal article
- Published by Elsevier in Cell Calcium
- Vol. 51 (2) , 194-206
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Pharmacological Modulation of Diacylglycerol-Sensitive TRPC3/6/7 ChannelsCurrent Pharmaceutical Biotechnology, 2011
- Redox signaling and reactive oxygen species in hypoxic pulmonary vasoconstrictionRespiratory Physiology & Neurobiology, 2010
- International Union of Basic and Clinical Pharmacology. LXXVI. Current Progress in the Mammalian TRP Ion Channel FamilyPharmacological Reviews, 2010
- A Functional Single-Nucleotide Polymorphism in the TRPC6 Gene Promoter Associated With Idiopathic Pulmonary Arterial HypertensionCirculation, 2009
- Regulation of hypoxic pulmonary vasoconstriction: basic mechanismsEuropean Respiratory Journal, 2008
- Classical transient receptor potential channel 6 (TRPC6) is essential for hypoxic pulmonary vasoconstriction and alveolar gas exchangeProceedings of the National Academy of Sciences, 2006
- TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal functionNature Genetics, 2005
- PDGF stimulates pulmonary vascular smooth muscle cell proliferation by upregulating TRPC6 expressionAmerican Journal of Physiology-Cell Physiology, 2003
- The Transient Receptor Potential Protein Homologue TRP6 Is the Essential Component of Vascular α1-Adrenoceptor–Activated Ca2+-Permeable Cation ChannelCirculation Research, 2001
- Direct activation of human TRPC6 and TRPC3 channels by diacylglycerolNature, 1999